128 related articles for article (PubMed ID: 8295596)
1. The adequacy of management of women with CIN 2 and CIN 3 Pap smear abnormalities.
Windrum G
Med J Aust; 1994 Feb; 160(3):165-6. PubMed ID: 8295596
[No Abstract] [Full Text] [Related]
2. Pap smear screening in women under 30 in the Norwegian Coordinated Cervical Cancer Screening Program, with a comparison of immediate biopsy vs Pap smear triage of moderate dysplasia.
Nygård JF; Nygård M; Skare GB; Thoresen SO
Acta Cytol; 2006; 50(3):295-302. PubMed ID: 16780024
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of liquid-based Pap tests: comparison of concurrent liquid-based tests and cervical biopsies on 782 women with previously abnormal Pap smears.
Guo M; Hu L; Martin L; Liu S; Baliga M; Hughson MD
Acta Cytol; 2005; 49(2):132-8. PubMed ID: 15839615
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the atypical squamous cell Papanicolaou smear.
Maier RC; Schultenover SJ
Int J Gynecol Pathol; 1986; 5(3):242-8. PubMed ID: 3759323
[TBL] [Abstract][Full Text] [Related]
5. [Colposcopic-histologic results in 97 patients with mild dysplasia shown by Pap test].
Crescini C; Pezzica E; Artuso A; Comerio D; Reale D; Bonaldi A
Minerva Ginecol; 1991 Nov; 43(11):509-12. PubMed ID: 1784407
[TBL] [Abstract][Full Text] [Related]
6. Is the human papillomavirus test in combination with the Papanicolaou test useful for management of patients with diagnoses of atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions?
Lee NW; Kim D; Park JT; Kim A
Arch Pathol Lab Med; 2001 Nov; 125(11):1453-7. PubMed ID: 11698001
[TBL] [Abstract][Full Text] [Related]
7. Correlation of PAP smear findings with clinical findings and cervical biopsy.
Pradhan B; Pradhan SB; Mital VP
Kathmandu Univ Med J (KUMJ); 2007; 5(4):461-7. PubMed ID: 18604076
[TBL] [Abstract][Full Text] [Related]
8. [Results of pap smears and immunocytochemical detection of the p16 and Ki67 proteins in women with cervical intraepithelial neoplasia and cervical cancer].
Rokita W; Skawiński D; Zmelonek-Znamirowska A; Kedzia W; Karowicz-Bilińska A; Spaczyński R; Spaczyński M
Ginekol Pol; 2012 Nov; 83(11):822-6. PubMed ID: 23379189
[TBL] [Abstract][Full Text] [Related]
9. A prospective evaluation of "see and treat" in women with HSIL Pap smear results: is this an appropriate strategy?
Numnum TM; Kirby TO; Leath CA; Huh WK; Alvarez RD; Straughn JM
J Low Genit Tract Dis; 2005 Jan; 9(1):2-6. PubMed ID: 15870514
[TBL] [Abstract][Full Text] [Related]
10. 'Pap smear' for screening of precancerous conditions of cervix.
Noreen R; Qudussi H
J Ayub Med Coll Abbottabad; 2011; 23(2):41-4. PubMed ID: 24800339
[TBL] [Abstract][Full Text] [Related]
11. 'See and treat' electrosurgical loop excision of the cervical transformation zone.
Ferris DG; Hainer BL; Pfenninger JL; Zuber TJ
J Fam Pract; 1996 Mar; 42(3):253-7. PubMed ID: 8636676
[TBL] [Abstract][Full Text] [Related]
12. Can we improve the detection of glandular cervical lesions: the role and limitations of the Pap smear diagnosis atypical glandular cells (AGC).
Duska LR
Gynecol Oncol; 2009 Sep; 114(3):381-2. PubMed ID: 19647129
[No Abstract] [Full Text] [Related]
13. The adequacy of management of women with CIN 2 and CIN 3 Pap smear abnormalities.
Towler BP; Irwig LM; Shelley JM
Med J Aust; 1993 Oct; 159(8):523, 526-8. PubMed ID: 8412951
[TBL] [Abstract][Full Text] [Related]
14. The effect of delivery on regression of abnormal cervical cytologic findings.
Strinić T; Buković D; Karelović D; Bojić L; Stipić I
Coll Antropol; 2002 Dec; 26(2):577-82. PubMed ID: 12528284
[TBL] [Abstract][Full Text] [Related]
15. Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities.
Wright TC; Sun XW; Koulos J
Obstet Gynecol; 1995 Feb; 85(2):202-10. PubMed ID: 7824231
[TBL] [Abstract][Full Text] [Related]
16. Cytologic predictors of cervical intraepithelial neoplasia in women with an ASCUS Pap smear.
Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
Acta Cytol; 2000; 44(4):576-86. PubMed ID: 10934951
[TBL] [Abstract][Full Text] [Related]
17. Incidence of cervical intraepithelial neoplasia grade III, and cancer of the cervix uteri following a negative Pap-smear in an opportunistic screening.
Gram IT; Macaluso M; Stalsberg H
Acta Obstet Gynecol Scand; 1998 Feb; 77(2):228-32. PubMed ID: 9512333
[TBL] [Abstract][Full Text] [Related]
18. The borderline cervical smear: colposcopic and biopsy outcome.
al-Nafussi A; Rebello G; al-Yusif R; McGoogan E
J Clin Pathol; 2000 Jun; 53(6):439-44. PubMed ID: 10911801
[TBL] [Abstract][Full Text] [Related]
19. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
Liao SY; Stanbridge EJ
Cancer; 2000 Mar; 88(5):1108-21. PubMed ID: 10699902
[TBL] [Abstract][Full Text] [Related]
20. Cervicography for triage of women with mildly abnormal cervical cytology results.
Ferris DG; Schiffman M; Litaker MS
Am J Obstet Gynecol; 2001 Oct; 185(4):939-43. PubMed ID: 11641682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
